Clinical Services

ETANERCEPT (Enbrel, Tumour Necrosis Factor (TNF) antagonist)

ETANERCEPT (Enbrel, Tumour Necrosis Factor (TNF) antagonist)

DEFER:

  • If the donor taking this drug and for 12 months after treatment has ceased and the underline condition is not a deferral

ADDITIONAL INFORMATION

Etanercept is a fusion protein produced by recombinant DNA. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis

IBTS/MEDD/DSGDE/0001Attachment 4.158Ver 1.1

Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...